AU1734600A - Identification of glycosphingolipids that promote hiv-1 entry into cells - Google Patents
Identification of glycosphingolipids that promote hiv-1 entry into cellsInfo
- Publication number
- AU1734600A AU1734600A AU17346/00A AU1734600A AU1734600A AU 1734600 A AU1734600 A AU 1734600A AU 17346/00 A AU17346/00 A AU 17346/00A AU 1734600 A AU1734600 A AU 1734600A AU 1734600 A AU1734600 A AU 1734600A
- Authority
- AU
- Australia
- Prior art keywords
- glycosphingolipids
- entry
- cells
- identification
- promote hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10890398P | 1998-11-17 | 1998-11-17 | |
US60108903 | 1998-11-17 | ||
PCT/US1999/027341 WO2000029556A2 (fr) | 1998-11-17 | 1999-11-16 | Identification des glycosphingolipides qui favorisent la penetration du vih-1 dans les cellules |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1734600A true AU1734600A (en) | 2000-06-05 |
Family
ID=22324732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17346/00A Abandoned AU1734600A (en) | 1998-11-17 | 1999-11-16 | Identification of glycosphingolipids that promote hiv-1 entry into cells |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1734600A (fr) |
WO (1) | WO2000029556A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
JP4986335B2 (ja) * | 2001-05-15 | 2012-07-25 | 生化学工業株式会社 | Vdac機能阻害剤 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374548A (en) * | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
IL86650A0 (en) * | 1987-06-30 | 1988-11-30 | Biophor Corp | Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane |
WO1989002918A1 (fr) * | 1987-09-22 | 1989-04-06 | Arthur Allen Vandenbark | Procede de modulation selective de l'expression et de la fonction d'un determinant de surface cellulaire, et production de nouvelles cellules humaines ainsi produites |
IT1235011B (it) * | 1988-07-26 | 1992-06-16 | Fidia Farmaceutici | Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico |
US5955293A (en) * | 1989-10-17 | 1999-09-21 | New England Medical Center Hospitals, Inc. | Assays for shiga toxin and shiga-like toxins |
US5795869A (en) * | 1993-03-04 | 1998-08-18 | Fidia S.P.A. | Sulfated lyso-ganglioside derivatives |
US6291657B1 (en) * | 1993-05-13 | 2001-09-18 | Monsanto Company | Deoxygalactonojirimycin derivatives |
CA2163716C (fr) * | 1995-11-24 | 2009-05-19 | Clifford A. Lingwood | Compositions pharmaceutiques a base de verotoxine et traitements medicaux qui l'utilisent |
AU3390297A (en) * | 1996-06-14 | 1998-01-07 | Aaron Diamond Aids Research Center, The | Uses of a chemokine receptor for inhibiting hiv-1 infection |
WO1998026662A1 (fr) * | 1996-12-19 | 1998-06-25 | The Penn State Research Foundation | Composes et methodes pour traiter et prevenir les maladies bacteriennes et virales |
US5962302A (en) * | 1998-02-20 | 1999-10-05 | Incyte Pharmaceuticals, Inc. | Human N-acetylneuraminate lyase |
-
1999
- 1999-11-16 WO PCT/US1999/027341 patent/WO2000029556A2/fr active Application Filing
- 1999-11-16 AU AU17346/00A patent/AU1734600A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000029556A2 (fr) | 2000-05-25 |
WO2000029556A3 (fr) | 2000-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL138631A0 (en) | Bicyclic hydroxamic acid derivatives | |
GB9900396D0 (en) | Arrangements of electrochemical cells | |
EP1137092A4 (fr) | Cellule secondaire | |
IL134300A0 (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
IL131123A0 (en) | Arylsulfonyl hydroxamic acid derivatives | |
AP9901505A0 (en) | (4-arylsulfonylamino)- etrah dropyran-4-carboxylic acid hydroxamides | |
AU2716299A (en) | Electrochrome cell | |
AU2832399A (en) | B cell inhibitors | |
AU5471600A (en) | Variant tlr4 nucleic acid and uses thereof | |
AUPP924799A0 (en) | Improved separator and process | |
GB9824444D0 (en) | Micro-Organism identification | |
AUPP193498A0 (en) | Cemetery walls | |
AU1734600A (en) | Identification of glycosphingolipids that promote hiv-1 entry into cells | |
AU1819599A (en) | Process for the preparation of alkylene carbonate | |
AU1381600A (en) | Identification of senv genotypes | |
AU4023700A (en) | Germline-competent avian cells | |
AU2180799A (en) | Neuroserpin | |
AU6006800A (en) | Treating cells | |
GB9912851D0 (en) | Treating cells | |
PL344481A1 (en) | Detergents containing amylase and percarboxylic acid | |
DE69840877D1 (en) | Icher | |
AU1220400A (en) | Disperser | |
AU4155399A (en) | Belt constructions | |
AU4582399A (en) | Electrooptic devices containing visible-light initiated electrolytes | |
AU7061298A (en) | Fracture cell apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |